US$ 22.14
discontinue sulfonylurea when starting glp-1 receptor agonist Clinical Focus on Agonists in Type 2 Diabetes Mellitus GLP-1 Receptor Agonists and Other
Description
doi: 10.2337/db12-0230

10.1002/med.21513 [DOI] [PubMed] [Google Scholar] 14.Nabeno M, Akahoshi F, Kishida H, Miyaguchi I, Tanaka Y, Ishii S, et al

Oral semaglutide for type 2 diabetes: A systematic review and meta-analysis

The anti-inflammatory effects may be both direct and indirect

N Engl J Med (2021) 385:896907

Purpose-built for physicians New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Key takeaways: GLP-1 agonists were associated with a 9.09 times increased risk for pancreatitis
